2010
DOI: 10.1172/jci40567
|View full text |Cite
|
Sign up to set email alerts
|

KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
386
2
11

Year Published

2011
2011
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 341 publications
(406 citation statements)
references
References 188 publications
7
386
2
11
Order By: Relevance
“…In addition, systemic ganciclovir treatment of AIDS patients reduced the incidence of Kaposi's sarcoma during the follow-up period (25). These observations suggest that lytic replication is also important for viral persistence and, in the case of HHV-8, for Kaposi's sarcoma progression (17). Though our observations show that latency is the predominant mode of AlHV-1 infection during WD-MCF, the role of lytic AlHV-1 replication in WD-MCF remains unknown.…”
Section: Discussionmentioning
confidence: 91%
“…In addition, systemic ganciclovir treatment of AIDS patients reduced the incidence of Kaposi's sarcoma during the follow-up period (25). These observations suggest that lytic replication is also important for viral persistence and, in the case of HHV-8, for Kaposi's sarcoma progression (17). Though our observations show that latency is the predominant mode of AlHV-1 infection during WD-MCF, the role of lytic AlHV-1 replication in WD-MCF remains unknown.…”
Section: Discussionmentioning
confidence: 91%
“…To spread within an individual or to new hosts, the virus must periodically reactivate to enter a lytic cycle, during which most viral genes are expressed, resulting in the production of infectious progeny and ultimately cell death. Despite its cell-destructive nature, the lytic cycle is believed to play key roles in the development of KSHV malignancies (Ganem 2010). The study of host responses to KSHV lytic replication is therefore crucial for understanding KSHV pathogenesis.…”
Section: [Supplemental Materials Is Available For This Article]mentioning
confidence: 99%
“…The multidrug antiretroviral regimens intervention based on a combination of reverse transcriptase and PIs have improved the clinical outcome of HIV-1 infection indicated by an important decline in AIDS incidence and mortality, but, on the other hand, they almost contribute to the oxidative metabolism which adds risk of molecular damage and replication of diverse virus contributing to polyp pathology condition [2,48,49]. These findings could be explained in part by several mechanisms such as low intake of antioxidants or their precursors, malabsorption and, in peripheral tissue, enhanced cysteine metabolism with a consequent loss of sulfur group which may account for GSH and antioxidant deficiency during HIV infection which persists after antiretroviral therapy [14,15,50,51]. Considering those aspects the exploration of redox status before antiretroviral therapy is encouraged in different conditions.…”
Section: Discussionmentioning
confidence: 99%